You just read:

Vtesse Advances Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease with Dose Selection for Evaluation in Second and Final Portion of Trial and Expansion into Europe

News provided by

Vtesse, Inc.

23 May, 2016, 07:00 ET